| prov:value
| - The Parkinson's Progression Markers Initiative is funded by the Michael J. Fox Foundation and 13 pharmaceutical and medical device companies.Study authors reported financial relationships with a large number of pharmaceutical and medical device companies including Pfizer, GE Healthcare, Merck, Lilly, Bristol-Myers Squibb, Abbott, AstraZeneca, Biogen Idec, Roche, Pramal, Neotope, NeuroPhage, Biotie
|